Skip to main content
James Ford, DO, Pediatric Hematology & Oncology, Salt Lake City, UT

JamesBFordDO

Pediatric Hematology & Oncology Salt Lake City, UT

Pediatric Hematologic Oncology

Associate Professor, Pediatrics, U of Utah Coll of Med

Dr. Ford is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ford's full profile

Already have an account?

  • Office

    81 N Mario Capecchi Dr
    Salt Lake City, UT 84113
    Phone+1 801-442-3229

Summary

  • Dr. James Ford is a pediatric hematologist/oncologist in Omaha, NE and is affiliated with multiple hospitals in the area, including Nebraska Medicine - Nebraska Medical Center and Children's Hospital and Medical Center. He received his medical degree from Des Moines University College of Osteopathic Medicine. He also speaks multiple languages, including Spanish and Portuguese. He specializes in pediatric hematologic oncology.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Hematology/Oncology, 2011 - 2014
  • Children's Hospital Medical Center of Akron/NEOMED
    Children's Hospital Medical Center of Akron/NEOMEDResidency, Pediatrics, 2008 - 2011
  • Des Moines University College of Osteopathic Medicine
    Des Moines University College of Osteopathic MedicineClass of 2008

Certifications & Licensure

  • UT State Medical License
    UT State License 2023 - 2026
  • NE State Medical License
    NE State License 2014 - 2024
  • CO State Medical License
    CO State License 2011 - 2015
  • OH State Medical License
    OH State License 2008 - 2011
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Academic faculty of the month Voted on by Residents at Childrens hospital Omaha September 2017 and December 2018
  • Abstract Achievement Award ASH, 2013
  • Excellence in resident teaching award Akron Children�s Hospital, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Breast Cancer and Non-Hodgkin Lymphoma in a Young Male with Cowden Syndrome  
    Hagelstrom RT, Ford J, Reiser GM, Nelson M, Pickering DL, Althof PA, Sanger WG, Coccia PF, Pediatric Blood & Cancer, 1/1/2016
  • Inhibition of Wee1 sensitizes cancer cells to anti-metabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality  
    Van Linden A, Baturin D, Fosmire S, Ford J, Gardner L, Korch C, Reigan P, Porter C, Mol Cancer Ther, 1/11/2013

Abstracts/Posters

  • Incidence and characteristics of Post-transplant lymphoproliferative disorder in pediatric patients following intestinal transplant
    Erin Oeltjen, Makayla Schissel MPH, Kelly Erickson MPH, Shaheed Merani MD PhD, James Ford DO, ASPHO, Pittsburgh, PA, 5/5/2022
  • Outcome of Post Solid Organ Transplant Burkitt Lymphoma (PSOT-BL): A Report from the Pediatric PTLD Collaborative (PPC)
    Zeinab Afify, MD, Manuela Orjuela, MD, ScM, Christine Moore Smith, MD, Mansi Dalal, MD, James B. Ford, DO, Pallavi Pillai, Joanna Robles, MD, Sonika Reddy, MD, Sarah M..., ASH 63rd annual meeting, Atlanta, GA, 12/8/2021
  • Children are 6 times more likely that adults to develop Post-Transplant Lymphoproliferative Disease.
    Ford JB, Sanmann J, Erickson K, Bast M, Grant W, Shostrom V, Langnas A, Greiner T, Coccia P, BJH; 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, The Netherlands, 1/1/2018
  • Join now to see all

Lectures

  • Children are 6 times more likely that adults to develop Post-Transplant Lymphoproliferative Disease. 
    Rotterdam, The Netherlands - 1/1/2018
  • Identification of Congenital Marrow Failure Syndromes in Children and Adults. Presented at Bone marrow failure disease symposium: A multidisciplinary approach to enhan... 
    Omaha, NE - 1/1/2017
  • Difficulties facing families with a child undergoing cancer treatment. 
    Green Bay, WI - 1/1/2017
  • Join now to see all

Grant Support

  • Tropolones as a novel therapeutic strategy for OsteosarcomaHyundai Hope on Wheels2021–2024

Committees

  • Panel member, NCCN Pediatric Aggresive Mature B-Cell Lymphoma 2019 - Present
  • member, Children's Oncology Group Non-Hodgkin's Lymphoma group

Professional Memberships

Other Languages

  • Spanish, Portuguese